EGFR and non-small cell lung carcinoma: The present case demonstrates that in EGFR mutation-positive NSCLC patients with acute right heart failure or hemodynamic collapse due to PTTM, VA-ECMO can serve as an effective bridge therapy when combined with molecular targeted treatment.